The Wilms' tumor antigen is a novel target for human CD4+ regulatory T cells: implications for immunotherapy. [electronic resource]
- Cancer research Aug 2008
- 6350-9 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1538-7445
10.1158/0008-5472.CAN-08-0050 doi
Amino Acid Sequence Antigens, Neoplasm--immunology Base Sequence CD4-Positive T-Lymphocytes--immunology DNA Primers Enzyme-Linked Immunosorbent Assay Flow Cytometry Humans Immunotherapy Molecular Sequence Data Reverse Transcriptase Polymerase Chain Reaction Wilms Tumor--immunology